Seres Therapeutics, Inc. (MCRB)

NMS – Real Time Price. Currency in USD

7.96

+0.01 (0.13%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

789K

Cost of goods sold

-4M

-15M

-12M

Gross Profit

-3M

-15M

-5M

Operating expenses (excl. COGS)

-91M

-103M

-180M

-241M

Operating Income

-94M

-118M

-195M

-245M

Non-operating income, total

100M

-8M

-5M

Pretax income

-126M

-190M

-250M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-126M

-190M

-250M

Seres Therapeutics, Inc. (MCRB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Seres Therapeutics, Inc. (MCRB)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Seres Therapeutics, Inc. (MCRB)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Seres Therapeutics, Inc. (MCRB)

Income Statement (Annual)

Income Statement (Annual)